Ivaylo Stoimenov

Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers

Åkerrén Ögren, Jim; Ekström, Joakim; Rameika, Natallia; Torell, Emma et al.

Part of Molecular Cancer, 2026

• DOI for Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers
• Download full text (pdf) of Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers

Biomarker discovery study design consistent with the receiver-operator characteristic

Ekström, Joakim; Stoimenov, Ivaylo; Åkerrén Ögren, Jim; Sjöblom, Tobias

Part of Computer Methods and Programs in Biomedicine, 2026

• DOI for Biomarker discovery study design consistent with the receiver-operator characteristic
• Download full text (pdf) of Biomarker discovery study design consistent with the receiver-operator characteristic

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

Rameika, Natallia; Tsiara, Ioanna; Zhang, Xiaonan; Haberek, Wawrzyniec et al.

Part of Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025

• DOI for NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
• Download full text (pdf) of NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib

Zhang, Xiaonan; Rameika, Natallia; Zhong, Lei; Veanes, Margus et al.

Part of EBioMedicine, 2024

• DOI for Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
• Download full text (pdf) of Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib

Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells

Kundu, Snehangshu; Nunes, Luís; Adler, Jeremy; Mathot, Lucy et al.

Part of Cell Communication and Signaling, 2023

• DOI for Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells
• Download full text (pdf) of Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells

Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers

Åkerrén Ögren, Jim; Ekström, Joakim; Rameika, Natallia; Torell, Emma et al.

Part of Molecular Cancer, 2026

• DOI for Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers
• Download full text (pdf) of Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers

Biomarker discovery study design consistent with the receiver-operator characteristic

Ekström, Joakim; Stoimenov, Ivaylo; Åkerrén Ögren, Jim; Sjöblom, Tobias

Part of Computer Methods and Programs in Biomedicine, 2026

• DOI for Biomarker discovery study design consistent with the receiver-operator characteristic
• Download full text (pdf) of Biomarker discovery study design consistent with the receiver-operator characteristic

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

Rameika, Natallia; Tsiara, Ioanna; Zhang, Xiaonan; Haberek, Wawrzyniec et al.

Part of Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025

• DOI for NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors
• Download full text (pdf) of NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib

Zhang, Xiaonan; Rameika, Natallia; Zhong, Lei; Veanes, Margus et al.

Part of EBioMedicine, 2024

• DOI for Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
• Download full text (pdf) of Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib

Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells

Kundu, Snehangshu; Nunes, Luís; Adler, Jeremy; Mathot, Lucy et al.

Part of Cell Communication and Signaling, 2023

• DOI for Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells
• Download full text (pdf) of Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells

Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity

Zhang, Xiaonan; Akcan, Ece; Correia, Mario S. P.; Rameika, Natallia et al.

Part of Biochemical Pharmacology, 2022

• DOI for Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity
• Download full text (pdf) of Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer

Rendo, Verónica; Kundu, Snehangshu; Rameika, Natallia; Ljungström, Viktor et al.

Part of Scientific Reports, 2020

• DOI for Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
• Download full text (pdf) of Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy

Rendo, Verónica; Stoimenov, Ivaylo; Mateus, André; Sjöberg, Elin et al.

Part of Nature Communications, 2020

• DOI for Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
• Download full text (pdf) of Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy

Targeting tumor vulnerabilities associated with loss of heterozygosity

Rendo, Veronica; Stoimenov, Ivaylo; Sjöblom, Tobias

Part of Molecular & Cellular Oncology, 2020

• DOI for Targeting tumor vulnerabilities associated with loss of heterozygosity
• Download full text (pdf) of Targeting tumor vulnerabilities associated with loss of heterozygosity

Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth

Pandzic, Tatjana; Rendo, Verónica; Lim, Jinyeong; Larsson, Chatarina et al.

Part of Oncotarget, p. 98646-98659, 2017

• DOI for Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth

Computational and molecular tools for scalable rAAV-mediated genome editing

Stoimenov, Ivaylo; Ali, Muhammad Akhtar; Pandzic, Tatjana; Sjöblom, Tobias

Part of Nucleic Acids Research, 2015

• DOI for Computational and molecular tools for scalable rAAV-mediated genome editing

Novel anti-cancer agents targeting NAT2 loss in colorectal cancer

Rameika, Natallia; Tsiara, Ioanna; Haberek, Wawrzyniec; Akcan, Ece et al.